90% of paperwork submitted by Bharat Biotech, say sources
The government on Monday “took stock” of Bharat Biotech’s application process with the World Health Organisation (WHO) for regulatory clearances for the Covaxin vaccine, as an inter-ministerial group led by Foreign Secretary Harsh Shringla met with company representatives in Delhi.
The meeting, that included senior officials from the Ministry of External Affairs, Ministry of Health, and Department of Biotechnology, with Bharat Biotech International Limited (BBIL) Managing Director Dr. Krishna Mohan, went over the paperwork submitted in April for the WHO’s Emergency Use Listing (EUL), amidst concerns that Indians who have taken Covaxin doses will face travel restrictions without global regulatory approval.
Bharat Biotech Submitted 90 Per Cent Of Documents To Who For Obtaining Emergency Use Listing For Covaxin Vaccine - कोवाक्सिन : भारत बायोटेक ने डब्ल्यूएचओ से मांगी आपात इस्तेमाल की मंजूरी, अब तक 90 फीसदी दस्तावेज किए जमा
amarujala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from amarujala.com Daily Mail and Mail on Sunday newspapers.
bharat biotech covaxin who approval: Bharat Biotech submitted 90 per cent of documentation to WHO for emergency use listing for Covaxin: भारत बायोटेक ने कोवैक्सीन को सूचीबद्ध कराने के लिए 90 फीसदी दस्तावेज WHO को सौंपे
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.